Literature DB >> 2805380

Identification of a second "French Canadian" LDL receptor gene deletion and development of a rapid method to detect both deletions.

Y H Ma1, C Bétard, M Roy, J Davignon, A M Kessling.   

Abstract

Hobbs et al. (N. Engl. J. Med. 317: 734-737, 1987) reported a large deletion of approximately 10 kilobases in the 5' portion of the human low-density lipoprotein (LDL) receptor gene. This deletion affects about 60% of familial hypercholesterolemia (FH) heterozygotes in the French Canadian population. We have developed a rapid, convenient method for the detection of the deletion using double digestion with the restriction enzymes XbaI and EcoRV, or triple digestion with XbaI, EcoRV and XmnI, and a 650 bp cDNA probe, radio-labeled using a random oligonucleotide primer technique. Eighty French Canadian FH heterozygotes were screened for the presence of the deletion. Forty-seven (59%) of them were found to carry the 10 kb deletion. Using the same method, we also identified a new mutation which was found in four of the 80 (5%) FH patients. This mutation has been found to be a 5 kb deletion removing exons 2 and 3 of the LDL receptor gene, which correspond to the first two repeats of the LDL receptor binding domain. Cosegregation of the 5 kb deletion and the FH phenotype was observed in one family. Possible structure-function relationship is discussed.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2805380     DOI: 10.1111/j.1399-0004.1989.tb03194.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  Common low-density lipoprotein receptor mutations in the French Canadian population.

Authors:  E Leitersdorf; E J Tobin; J Davignon; H H Hobbs
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

2.  Role of rs3846662 and HMGCR alternative splicing in statin efficacy and baseline lipid levels in familial hypercholesterolemia.

Authors:  Valerie Leduc; Lucienne Bourque; Judes Poirier; Robert Dufour
Journal:  Pharmacogenet Genomics       Date:  2016-01       Impact factor: 2.089

Review 3.  Heterozygous familial hypercholesterolemia: an underrecognized cause of early cardiovascular disease.

Authors:  George Yuan; Jian Wang; Robert A Hegele
Journal:  CMAJ       Date:  2006-04-11       Impact factor: 8.262

4.  Genealogical analysis as a new approach for the investigation of drug intolerance heritability.

Authors:  Marc Tremblay; Tarek Bouhali; Daniel Gaudet; Diane Brisson
Journal:  Eur J Hum Genet       Date:  2013-11-27       Impact factor: 4.246

5.  Polymorphic haplotypes and recombination rates at the LDL receptor gene locus in subjects with and without familial hypercholesterolemia who are from different populations.

Authors:  A R Miserez; H Schuster; N Chiodetti; U Keller
Journal:  Am J Hum Genet       Date:  1993-04       Impact factor: 11.025

6.  Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians.

Authors:  C Bétard; A M Kessling; M Roy; A Chamberland; S Lussier-Cacan; J Davignon
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

7.  Evidence for a cholesterol-lowering gene in a French-Canadian kindred with familial hypercholesterolemia.

Authors:  C Sass; L M Giroux; Y Ma; M Roy; J Lavigne; S Lussier-Cacan; J Davignon; A Minnich
Journal:  Hum Genet       Date:  1995-07       Impact factor: 4.132

8.  Phenotypic heterogeneity associated with defective apolipoprotein B-100 and occurrence of the familial hypercholesterolemia phenotype in the absence of an LDL-receptor defect within a Canadian kindred.

Authors:  J Davignon; R Dufour; M Roy; C Bétard; Y Ma; S Ouellette; L Boulet; S Lussier-Cacan
Journal:  Eur J Epidemiol       Date:  1992-05       Impact factor: 8.082

9.  In search of a genetic explanation for LDLc variability in an FH family: common SNPs and a rare mutation in MTTP explain only part of LDL variability in an FH family.

Authors:  Michael Winther; Shoshi Shpitzen; Or Yaacov; Jakob Landau; Limor Oren; Linda Foroozan-Rosenberg; Naama Lev Cohain; Daniel Schurr; Vardiela Meiner; Auryan Szalat; Shai Carmi; Michael R Hayden; Eran Leitersdorf; Ronen Durst
Journal:  J Lipid Res       Date:  2019-08-06       Impact factor: 5.922

10.  Apolipoprotein E and lipoprotein lipase gene polymorphisms interaction on the atherogenic combined expression of hypertriglyceridemia and hyperapobetalipoproteinemia phenotypes.

Authors:  P Perron; D Brisson; M Santuré; P Blackburn; J Bergeron; M C Vohl; J P Després; D Gaudet
Journal:  J Endocrinol Invest       Date:  2007 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.